Contributing Member of the Healthcare Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

New Technology for treatment of sepsis

February 24, 2009

Analysis of:Discontinuation of Development of TAK-242 for Severe Sepsis | www.pipelinereview.com

New technology has been developed that may play a role in the treatment of sepsis and hypoostension. This involves the development of a vagal nerve stimulator. A start-up company based in New Jersey- Electocore, has looked at animal models of epsis and hypotension and has found significant merit in their unique electrical signal for nerve stimulation to treat hypotension related to sepsis.

Page : 11 to 1 of 1

Subscribe to Updates

By RSS